[144] Fate Therapeutics, Inc. SEC Filing
Filing Impact
Filing Sentiment
Form Type
144
Fate Therapeutic
NASDAQ:FATE
FATE Rankings
FATE Latest News
Feb 26, 2026
Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Feb 3, 2026
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
FATE Latest SEC Filings
Feb 26, 2026
[10-K] FATE THERAPEUTICS INC Files Annual Report
Feb 26, 2026
[8-K] FATE THERAPEUTICS INC Reports Material Event
FATE Stock Data
179.95M
113.16M
Biotechnology
Biological Products, (no Diagnostic Substances)
United States
SAN DIEGO